Stockscreener 앱 받기
2.41
0.42%
0.01
시간 외 거래:
2.41
전일 마감가:
$2.40
열려 있는:
$2.41
하루 거래량:
40,406
Relative Volume:
0.24
시가총액:
$6.98M
수익:
-
순이익/손실:
$-5.85M
주가수익비율:
-0.3604
EPS:
-6.6877
순현금흐름:
$-8.00M
1주 성능:
+3.88%
1개월 성능:
-1.23%
6개월 성능:
-60.03%
1년 성능:
-86.74%
1일 변동 폭
$2.36
$2.42
1주일 범위
$2.26
$2.45
52주 변동 폭
$2.06
$18.72
Alzamend Neuro Inc Stock (ALZN) Company Profile
명칭
Alzamend Neuro Inc
전화
844-722-6333
주소
3500 LENOX RD. NE, ATLANTA
ALZN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
2.41 | 7.38M | 0 | -5.85M | -8.00M | -6.6877 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-01 | 개시 | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc 주식(ALZN)의 최신 뉴스
Is Alzamend Neuro Inc. meeting your algorithmic filter criteria2025 Major Catalysts & Smart Money Movement Alerts - Newser
Real time breakdown of Alzamend Neuro Inc. stock performanceWeekly Stock Summary & Daily Stock Trend Reports - Newser
What does recent volatility data suggest for Alzamend Neuro Inc.July 2025 PreEarnings & Real-Time Volume Surge Alerts - Newser
How to use a screener to detect Alzamend Neuro Inc. breakoutsNew Guidance & Verified Momentum Watchlists - Newser
Technical signs of recovery in Alzamend Neuro Inc.Risk Management & Weekly High Conviction Ideas - Newser
Will breakout in Alzamend Neuro Inc. lead to full recoveryJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - Newser
Can swing trading help recover from Alzamend Neuro Inc. lossesDividend Hike & Real-Time Stock Movement Alerts - Newser
Key metrics from Alzamend Neuro Inc.’s quarterly dataTrade Entry Report & High Conviction Trade Alerts - Newser
Is this a good reentry point in Alzamend Neuro Inc.July 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
Multi factor analysis applied to Alzamend Neuro Inc.New Guidance & Verified Momentum Stock Watchlist - Newser
Will a bounce in Alzamend Neuro Inc. offer an exit2025 Investor Takeaways & AI Powered Market Entry Ideas - Newser
Will Alzamend Neuro Inc. bounce back from current supportMarket Growth Review & Growth-Oriented Investment Plans - Newser
Using flow based indicators on Alzamend Neuro Inc.Market Movers & Proven Capital Preservation Methods - Newser
Developing predictive dashboards with Alzamend Neuro Inc. dataBuy Signal & Weekly Stock Performance Updates - Newser
Visual trend scoring systems applied to Alzamend Neuro Inc.July 2025 Earnings & Reliable Entry Point Alerts - Newser
Using economic indicators to assess Alzamend Neuro Inc. potential2025 Short Interest & Risk Adjusted Buy and Sell Alerts - Newser
Tick level data insight on Alzamend Neuro Inc. volatility2025 Market WrapUp & Scalable Portfolio Growth Ideas - Newser
How hedge fund analytics apply to Alzamend Neuro Inc. stock2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
Can machine learning forecast Alzamend Neuro Inc. recoveryEarnings Performance Report & Precise Swing Trade Entry Alerts - Newser
real time breakdown of alzamend neuro inc. stock performanceQuarterly Portfolio Summary & Growth Oriented Trading Recommendations - Newser
Chart based analysis of Alzamend Neuro Inc. trends2025 Earnings Impact & Capital Protection Trading Alerts - Newser
Can you recover from losses in Alzamend Neuro Inc.2025 Key Lessons & Low Risk High Win Rate Stock Picks - Newser
Price action breakdown for Alzamend Neuro Inc.Exit Point & Daily Stock Trend Reports - Newser
How to monitor Alzamend Neuro Inc. with trend dashboards2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight - GlobeNewswire Inc.
Sentiment analysis tools applied to Alzamend Neuro Inc.Watch List & Real-Time Buy Signal Alerts - Newser
relative strength of alzamend neuro inc. in sector analysisWeekly Volume Report & Real-Time Market Sentiment Reports - Newser
What to expect from Alzamend Neuro Inc. in the next 30 daysJuly 2025 Price Swings & Verified Trade Idea Suggestions - Newser
Alzamend Neuro, Inc. SEC 10-Q Report - TradingView
What technical models suggest about Alzamend Neuro Inc.’s comebackJuly 2025 Opening Moves & Consistent Profit Trade Alerts - Newser
key metrics from alzamend neuro inc.’s quarterly dataJuly 2025 Breakouts & Reliable Trade Execution Plans - Newser
Can Alzamend Neuro Inc. hit a new high this month2025 Analyst Calls & Weekly High Return Forecasts - Newser
How to recover losses in Alzamend Neuro Inc. stockJuly 2025 Closing Moves & Low Risk Investment Opportunities - Newser
Published on: 2025-09-10 00:51:48 - Newser
Will Alzamend Neuro Inc. continue its uptrendWatch List & AI Driven Stock Price Forecasts - Newser
Alzamend Neuro Inc (ALZN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Alzamend Neuro Inc 주식 (ALZN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| AULT MILTON C III | Director |
Jul 30 '25 |
Sale |
2.51 |
29,449 |
73,982 |
108,260 |
| AULT MILTON C III | Director |
Jul 25 '25 |
Sale |
2.90 |
36,532 |
105,855 |
46,020 |
| AULT MILTON C III | Director |
Jul 28 '25 |
Sale |
2.68 |
8,311 |
22,314 |
37,709 |
| AULT MILTON C III | Director |
Jul 23 '25 |
Sale |
2.95 |
59,516 |
175,584 |
92,173 |
| AULT MILTON C III | Director |
Jul 24 '25 |
Sale |
2.93 |
9,621 |
28,237 |
82,552 |
| AULT MILTON C III | Director |
May 12 '25 |
Sale |
5.06 |
1,213 |
6,138 |
8,260 |
| AULT MILTON C III | Director |
May 12 '25 |
Sale |
5.28 |
11 |
58 |
1,843 |
0.93%
0.10%
자본화:
|
볼륨(24시간):